Protein detail

LPP

Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma)

Entry name
LPP
UniProt ID
EVMP confidence score
0.60
Supporting publications (n)
18
Transmembrane count
Protein classification
Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information10
Protein Names
Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma)
Protein Class (5)
Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins
Protein Function (4)
  • Cancer-related genes:Mutational cancer driver genes
  • Human disease related genes:Cancers:Cancers of haematopoietic and lymphoid tissues
  • Disease related genes
  • Predicted intracellular proteins
Entrez Gene Symbol
Gene Description
LIM domain containing preferred translocation partner in lipoma
Chromosome
3
Position
188153284-188890671
Supporting publications (n)
18
EVMP confidence score
0.60
Fluorescence & Localization5
LPP fluorescence
Cell SpecificAdipocytesSingle-Nuclei Brain SpecificastrocyteBlood Cell SpecificeosinophilBlood Lineage Specificgranulocytes
Function & Pathway5
Protein Function (4)
  • Cancer-related genes:Mutational cancer driver genes
  • Human disease related genes:Cancers:Cancers of haematopoietic and lymphoid tissues
  • Disease related genes
  • Predicted intracellular proteins
Mediation Categories
Adhesion and uptake mediation
Relations & Evidence54

Enzyme-Mediated Modification (8)

8 records.

Substrate Gene SymbolEnzyme Gene SymbolEnzyme UniProt IDResidue TypeResidue OffsetModificationDatabaseReferences
LPPSRCP12931Y301phosphorylationPhosphoSitePhosphoSite_ProtMapperProtMapper
LPPSRCP12931Y244phosphorylationPhosphoSitePhosphoSite_ProtMapperProtMapper
LPPSRCP12931Y300phosphorylationPhosphoSitePhosphoSite_ProtMapperProtMapper
LPPEGFRP00533Y301phosphorylationBEL-Large-Corpus_ProtMapperProtMapperProtMapper:15951569
LPPEGFP01133S116phosphorylationBEL-Large-Corpus_ProtMapperProtMapperProtMapper:17081983
LPPIGF1RP08069Y300phosphorylationKEAKEA:17570479
LPPINSRP06213Y301phosphorylationKEAKEA:17570479
LPPLCKP06239Y301phosphorylationKEAKEA:17570479

Ligand-Receptor Signaling (16)

16 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
receptorreceptorOmniPathNoYesNoNoNo
intracellularintracellularLOCATENoNoNoNoNo
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularUniProt_locationNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo
matrix_adhesionmatrix_adhesionZhong2015NoYesNoNoNo
focal_adhesionmatrix_adhesionZhong2015NoYesNoNoNo
adhesionadhesionOmniPathYesYesNoNoNo
matrix_adhesionmatrix_adhesionOmniPathNoYesNoNoNo
Page 1 of 2Next

Regulatory Interaction Network (1)

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
SRCP12931LPPQ93052YesNoNoPhosphoSite_norefPhosphoSitePhosphoSite_ProtMapperProtMapperPhosphoSite:28436416

Protein Complex Composition (28)

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry130950185
Sequence, Structure & Domains8

Sequences

Length
612
Mass
65,746
Sequence
MSHPSWLPPKSTGEPLGHVPARMETTHSFGNPSISVSTQQPPKKFAPVVAPKPKYNPYKQPGGEGDFLPPPPPPLDDSSALPSISGNFPPPPPLDEEAFKVQGNPGGKTLEERRSSLDAEIDSLTSILADLECSSPYKPRPPQSSTGSTASPPVSTPVTGHKRMVIPNQPPLTATKKSTLKPQPAPQAGPIPVAPIGTLKPQPQPVPASYTTASTSSRPTFNVQVKSAQPSPHYMAAPSSGQIYGSGPQGYNTQPVPVSGQCPPPSTRGGMDYAYIPPPGLQPEPGYGYAPNQGRYYEGYYAAGPGYGGRNDSDPTYGQQGHPNTWKREPGYTPPGAGNQNPPGMYPVTGPKKTYITDPVSAPCAPPLQPKGGHSGQLGPSSVAPSFRPEDELEHLTKKMLYDMENPPADEYFGRCARCGENVVGEGTGCTAMDQVFHVDCFTCIICNNKLRGQPFYAVEKKAYCEPCYINTLEQCNVCSKPIMERILRATGKAYHPHCFTCVMCHRSLDGIPFTVDAGGLIHCIEDFHKKFAPRCSVCKEPIMPAPGQEETVRIVALDRDFHVHCYRCEDCGGLLSEGDNQGCYPLDGHILCKTCNSARIRVLTAKASTDL

Domain & Motif Annotations

Compositional Bias
26..40; Polar residues; 41..53; Low complexity; 143..158; Polar residues; 171..181; Polar residues; 183..193; Pro residues; 209..219; Polar residues; 314..323; Polar residues
Domain (FT)
414..473; LIM zinc-binding 1; 474..534; LIM zinc-binding 2; 535..603; LIM zinc-binding 3
Region
1..118; Disordered; 132..219; Disordered; 307..387; Disordered
Protein Families
Zyxin/ajuba family
Sequence Similarities
Belongs to the zyxin/ajuba family.
Clinical Relevance5
Disease Involvement
Cancer-related genes
Interaction Protein
ENSG00000105568
Interaction Count
1
Interaction Dataset
biogrid_bioplex
Supporting Publications18
PMIDTitleAbstract
38113368In-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum.No abstract available
38207106Proteomic, Metabolomic, and Fatty Acid Profiling of Small Extracellular Vesicles from Glioblastoma Stem-Like Cells and Their Role in Tumor Heterogeneity.No abstract available
38716512Assessment of urine sample collection and processing variables for extracellular vesicle-based proteomics.No abstract available
39207047The trajectory of vesicular proteomic signatures from HBV-HCC by chitosan-magnetic bead-based separation and DIA-proteomic analysis.No abstract available
40189497Small extracellular vesicle-based one-step high-throughput microfluidic platform for epithelial ovarian cancer diagnosis.No abstract available
40465195Extracellular vesicle proteomics uncovers energy metabolism, complement system, and endoplasmic reticulum stress response dysregulation postexercise in males with myalgic encephalomyelitis/chronic fatigue syndrome.No abstract available
40985879TurboID-Mediated Profiling of Glioblastoma-Derived Extracellular Vesicle Cargo Proteins.No abstract available
41307968Extracellular Vesicles Define Discrete Nano-Based Niches Within the Human Haematopoietic System.No abstract available
Page 2 of 2Previous